Activated platelets were observed to interact with small cell lung cancer and neuroblastoma cell lines, and this interaction was blocked with inhibitory anti-P-selectin antibodies (Stone and Wagner, 1993), indicating that P-selectin is a key mediator of platelet-tumor interaction (Borsig, 2008). This evidence concerns the gene SELP and neoplasm.